Histamine: a potential cytoprotective agent to improve cancer therapy?

Cell Death Dis. 2015 Dec 31;6(12):e2029. doi: 10.1038/cddis.2015.378.
No abstract available

Publication types

  • News
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology*
  • Cytoprotection
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects*
  • Heart / drug effects
  • Histamine / administration & dosage
  • Histamine / pharmacology*
  • Humans
  • Mice
  • Rats
  • Rats, Sprague-Dawley
  • Rats, Wistar

Substances

  • Doxorubicin
  • Histamine